Krka: Slovenia’s Pharmaceutical Star, Shines with Resilience and Growth

In the highly competitive and often volatile global pharmaceuticals market, Slovenia’s Krka (WSE: KRK) has carved out a powerful niche as a leading generic drug manufacturer. With a disciplined strategy centered on vertical integration, geographic diversification, and consistent R&D investment, Krka has become a beacon of stability and a star performer …